---
reference_id: "PMID:25359349"
title: Severe haemoptysis in patients with nonsmall cell lung carcinoma.
authors:
- Razazi K
- Parrot A
- Khalil A
- Djibre M
- Gounant V
- Assouad J
- Carette MF
- Fartoukh M
- Cadranel J
journal: Eur Respir J
year: '2015'
doi: 10.1183/09031936.00010114
content_type: abstract_only
---

# Severe haemoptysis in patients with nonsmall cell lung carcinoma.
**Authors:** Razazi K, Parrot A, Khalil A, Djibre M, Gounant V, Assouad J, Carette MF, Fartoukh M, Cadranel J
**Journal:** Eur Respir J (2015)
**DOI:** [10.1183/09031936.00010114](https://doi.org/10.1183/09031936.00010114)

## Content

1. Eur Respir J. 2015 Mar;45(3):756-64. doi: 10.1183/09031936.00010114. Epub 2014
 Oct 30.

Severe haemoptysis in patients with nonsmall cell lung carcinoma.

Razazi K(1), Parrot A(2), Khalil A(3), Djibre M(1), Gounant V(4), Assouad J(5), 
Carette MF(6), Fartoukh M(7), Cadranel J(8).

Author information:
(1)AP-HP, Hôpital Tenon, Unité de Réanimation Médico-Chirurgicale, Pôle Thorax 
Voies Aériennes, Groupe Hospitalier des Hôpitaux Universitaires de l'Est 
Parisien, Paris, France.
(2)AP-HP, Hôpital Tenon, Unité de Réanimation Médico-Chirurgicale, Pôle Thorax 
Voies Aériennes, Groupe Hospitalier des Hôpitaux Universitaires de l'Est 
Parisien, Paris, France antoine.parrot@tnn.aphp.fr.
(3)AP-HP, Hôpital Tenon, Service de Radiologie, Pôle Imagerie, Groupe 
Hospitalier des Hôpitaux Universitaires de l'Est Parisien, Paris, France.
(4)AP-HP, Hôpital Tenon, Service de Pneumologie - Centre Expert en Oncologie 
Thoracique, Pôle Thorax Voies Aériennes, Groupe Hospitalier des Hôpitaux 
Universitaires de l'Est Parisien, Paris, France AP-HP, Hôpital Tenon, Service de 
Chirurgie Thoracique, Pôle Thorax Voies Aériennes, Groupe Hospitalier des 
Hôpitaux Universitaires de l'Est Parisien, Paris, France.
(5)AP-HP, Hôpital Tenon, Service de Chirurgie Thoracique, Pôle Thorax Voies 
Aériennes, Groupe Hospitalier des Hôpitaux Universitaires de l'Est Parisien, 
Paris, France Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
(6)AP-HP, Hôpital Tenon, Service de Radiologie, Pôle Imagerie, Groupe 
Hospitalier des Hôpitaux Universitaires de l'Est Parisien, Paris, France 
Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
(7)AP-HP, Hôpital Tenon, Unité de Réanimation Médico-Chirurgicale, Pôle Thorax 
Voies Aériennes, Groupe Hospitalier des Hôpitaux Universitaires de l'Est 
Parisien, Paris, France Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
(8)AP-HP, Hôpital Tenon, Service de Pneumologie - Centre Expert en Oncologie 
Thoracique, Pôle Thorax Voies Aériennes, Groupe Hospitalier des Hôpitaux 
Universitaires de l'Est Parisien, Paris, France Sorbonne Universités, UPMC Univ 
Paris 06, Paris, France.

Comment in
    Eur Respir J. 2015 Mar;45(3):601-3. doi: 10.1183/09031936.00199914.

Severe haemoptysis due to nonsmall cell lung cancer (NSCLC) is considered a grim 
condition, and there is still scarce data on its characteristics and outcome, 
despite new imaging and treatment modalities. This retrospective study sought to 
describe the clinical characteristics, pathophysiology and outcome of 
NSCLC-related haemoptysis. We included 125 consecutive patients with severe 
haemoptysis (>100 mL) at admission, 65 (52%) exhibiting squamous cell carcinoma. 
Tumour cavitation/necrosis was reported in 26 (21%) patients. 52 patients had 
received anticancer treatment, but none had received anti-angiogenic agents. 
Severe haemoptysis was related mainly to the bronchial artery (82%), and major 
pulmonary artery involvement was rare (6.4%). Interventional radiology was 
performed in 102 patients. Bleeding cessation was achieved in 108 (87%) out of 
125 patients. The overall in-hospital and 1-year survival rates were 69% and 
30%, respectively. Performance status (PS) ≥ 2 (OR 3.6, 95% CI 1.3-9.6), 
advanced stage (OR 8.6, 95% CI 2-37) and mechanical ventilation (OR 13, 95% CI 
4.5-36) were independent predictors of in-hospital mortality. Performance status 
≥ 2 (hazard ratio (HR) 2.4, 95% CI 1.5-3.7), advanced stage (HR 4, 95% CI 
2.1-7.7), cancer progression (HR 2, 95% CI 1.01-2.7) and cavitation/necrosis (HR 
1.7, 95% CI 1.21-3.2) were independently associated with 1-year mortality. 
Management of severe haemoptysis related to NSCLC should be improved, given our 
observed survival rates after hospital discharge.

Copyright ©ERS 2015.

DOI: 10.1183/09031936.00010114
PMID: 25359349 [Indexed for MEDLINE]